21 CFR §886.1342
Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov ↗
- (a)Identification. A strabismus detection device is a prescription device designed to simultaneously illuminate both eyes with polarized light for automated detection of strabismus by analyzing foveal birefringence properties.
- (b)Classification. Class II (special controls). The special controls for this device are:
- (1)Clinical performance testing must demonstrate the device performs as intended under anticipated conditions of use. Testing must be conducted in a representative patient population and clinical setting for the indicated use. Demonstration of clinical performance must include assessment of sensitivity and specificity compared to a clearly defined reference standard (e.g., comprehensive ophthalmological examination comprises age-appropriate visual acuity testing, examination of the external ocular adnexae and orbit, anterior segment evaluation, extraocular motility evaluation, assessment of stereopsis, cycloplegic refraction, and dilated fundus examination).
- (2)Non-clinical performance testing must demonstrate the device performs as intended under anticipated conditions of use. The following technical characteristics must be evaluated:
- (3)Software verification, validation, and hazard analysis must be performed.
- (4)Optical radiation safety testing must demonstrate the device is safe per the directions for use.
- (5)Performance testing must demonstrate the electromagnetic compatibility of the device.
- (6)Performance testing must demonstrate the electrical safety of the device.
- (7)Labeling must include the following: